Press Releases - 2023-11-14

Date	Title	Company
14-Nov-2023	Global Varicella Vaccines Industry Soars with a 6.3% CAGR, Projected to Reach US$ 5.76 Billion by 2032 \| FMI	MARKITWIRED
14-Nov-2023	Global Veterinary Services Industry Soars to Unprecedented Heights, Predicted to Reach US$ 244.4 Billion by 2032 \| FMI Analysis	MARKITWIRED
14-Nov-2023	Global Dental Plaster Industry Gears Up for US$ 238.6 Million Valuation by 2032, Riding on a 5.4% Growth Trajectory \| Says FMI Experts	MARKITWIRED
14-Nov-2023	Global Medical Chairs Industry Set to Skyrocket at a 6.0% CAGR, Projecting a Valuation of US$ 13.7 Billion by 2032 \| FMI	MARKITWIRED
14-Nov-2023	Global Caprolactam Industry Poised for a 3.9% CAGR Surge, Projected to Reach US$ 21.9 Billion by 2032	MARKITWIRED
14-Nov-2023	Abivax to participate in the Piper Sandler 35th Annual Healthcare Conference	ABIVAX
14-Nov-2023	Global Breast Imaging Industry Anticipated Surge to USD 8.5 Billion by 2032 at a Remarkable 7.1% CAGR \| FMI Expert View	MARKITWIRED
14-Nov-2023	Global Veterinary Dietary Supplements Industry Set for Remarkable 10.5% CAGR Surge from 2022 to 2032 \| FMI	MARKITWIRED
14-Nov-2023	Global Medical Telepresence Robots Industry Set to Skyrocket to US$ 459.1 Million by 2032 \| FMI Insights	MARKITWIRED
14-Nov-2023	Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels	UCB
14-Nov-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
14-Nov-2023	CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update	CureVac
14-Nov-2023	Pioneering AI innovation from RWS Offers Near Human-Quality Translation	Businesswire
14-Nov-2023	FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer	FluoGuide
14-Nov-2023	Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today	Oncopeptides
14-Nov-2023	Specialty Medical Chairs Market Trends : Projected to Surpass USD 7.9 billion by 2031, CAGR of 6.8% from 2022 to 2031	The Wire Times
14-Nov-2023	Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus	Tune Therapeutics
14-Nov-2023	Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria	Glox Therapeutics
14-Nov-2023	PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers	PureTech Health plc
14-Nov-2023	Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases	Almirall